Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk
- PMID: 33272367
- DOI: 10.1016/j.jacc.2020.10.029
Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk
Keywords: cardiovascular disease; general population; ischemic heart disease; lipoprotein; remnant cholesterol; triglycerides.
Conflict of interest statement
Author Disclosures Dr. Hegele has received consulting fees from Acasti, Aegerion, Akcea/Ionis, Amgen, HLS Therapeutics, Novartis, Regeneron, and Sanofi; is supported by the Jacob J. Wolfe Distinguished Medical Research Chair, the Edith Schulich Vinet Research Chair in Human Genetics, and the Martha G. Blackburn Chair in Cardiovascular Research; and has also received operating grants from the Canadian Institutes of Health Research (Foundation award) and the Heart and Stroke Foundation of Ontario (G-18-0022147). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.J Am Coll Cardiol. 2020 Dec 8;76(23):2712-2724. doi: 10.1016/j.jacc.2020.10.008. J Am Coll Cardiol. 2020. PMID: 33272365 Clinical Trial.
-
VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins.J Am Coll Cardiol. 2020 Dec 8;76(23):2725-2735. doi: 10.1016/j.jacc.2020.09.610. J Am Coll Cardiol. 2020. PMID: 33272366
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
